Redhill Biopharma - ADR

NASDAQ:RDHL   3:59:10 PM EDT
0.94
-0.01 (-0.74%)
Earnings Announcements

Redhill Biopharma Says Net Revenues For Q4 Of 2021 Were $22.1 Mln

Published: 03/17/2022 13:31 GMT
Redhill Biopharma - ADR (RDHL) - Redhill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results.
Net Revenues for Q4 of 2021 Were $22.1 Million, As Compared to $21.6 Million in Q3 of 2021.
Cash Balance As of December 31, 2021, Was $54.2 Million.
Q4 Revenue View $24.1 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $24.3 Million
Adjusted EPS is expected to be -$0.32

Next Quarter Revenue Guidance is expected to be $25.2 Million
Next Quarter EPS Guidance is expected to be -$0.30

More details on our Analysts Page.